Literature DB >> 1804731

Stress management for irritable bowel syndrome: a controlled trial.

G Shaw1, E D Srivastava, M Sadlier, P Swann, J Y James, J Rhodes.   

Abstract

Thirty-five patients with irritable bowel syndrome were randomized to receive treatment in a stress management programme or conventional therapy which included the antispasmodic Colpermin. The stress management programme involved a median of six 40-min sessions with a physiotherapist during which patients were helped to understand the nature of their symptoms, their relationship to stress and were taught relaxation exercises. Two thirds of those in the stress management programme found the programme effective in relieving symptoms and experienced fewer attacks of less severity. This benefit was maintained for at least 12 months. Few of those given conventional management had any benefit. A stress management programme would appear to be of value for patients with irritable bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1804731     DOI: 10.1159/000200738

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  16 in total

Review 1.  Non-pharmacological treatments in the irritable bowel syndrome.

Authors:  A Leahy; O Epstein
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

Review 2.  Treatment of irritable bowel syndrome: a review of randomised controlled trials.

Authors:  R Akehurst; E Kaltenthaler
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

3.  Diarrhea- and Constipation-predominant Irritable Bowel Syndrome.

Authors:  Richard Lea; Peter J. Whorwell
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

4.  Level of chronic life stress predicts clinical outcome in irritable bowel syndrome.

Authors:  E J Bennett; C C Tennant; C Piesse; C A Badcock; J E Kellow
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

Review 5.  Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care?

Authors:  Rosalind Raine; Andy Haines; Tom Sensky; Andrew Hutchings; Kirsten Larkin; Nick Black
Journal:  BMJ       Date:  2002-11-09

6.  Norepinephrine mediates the transcriptional effects of heterotypic chronic stress on colonic motor function.

Authors:  Barun K Choudhury; Xuan-Zheng Shi; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

Review 7.  The burden of IBS: looking at metrics.

Authors:  Brennan M R Spiegel
Journal:  Curr Gastroenterol Rep       Date:  2009-08

Review 8.  The interface of psychiatry and irritable bowel syndrome.

Authors:  David G Folks
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

9.  Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?

Authors:  Brennan M R Spiegel; William D Chey; Lin Chang
Journal:  Am J Gastroenterol       Date:  2008-12       Impact factor: 10.864

Review 10.  Across the developmental continuum of irritable bowel syndrome: clinical and pathophysiologic considerations.

Authors:  Andres Besedovsky; B U K Li
Journal:  Curr Gastroenterol Rep       Date:  2004-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.